3165011b (fluidigm)
93
Structured Review
fluidigm
3165011b
3165011b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3165011b/Anti-Human+CD45RO+(UCHL1)-165Ho/pmc13006393-90-9-5
Average 93 stars, based on 5 article reviews
3165011b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3165011b/Anti-Human+CD45RO+(UCHL1)-165Ho/pmc13006393-90-9-5
Average 93 stars, based on 5 article reviews
3165011b - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Recombinase Polymerase Amplification:Article Title: Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study Article Snippet: .. The list of CyTOF Abs used in this work: Metal Isotope, Antibody, Ab Amount (μl), Clone, Manufacturer, Catalogue#, LOT# (whenever available; if more than one LOT was used, they are split by '&') 154Sm CD3, 1, UCHT1, Fluidigm, 3154003B, 0151806 174Yb CD4, 1, SK3, Fluidigm, 3174004B, 2351715 146Nd CD8a, 1, RPA-T8, Fluidigm, 3146001B,1671716 209Bi CD11b, 1, ICRF44, Fluidigm, 3209003B, 0831723 160Gd CD14, 1, M5E2, Fluidigm, 3160001B, 3261702 164Dy CD15 (SSEA-1), 1, W6D3, Fluidigm, 3164001B, 1421725 148Nd CD16, 1, 3G8, Fluidigm, 3148004B, 2511709 142Nd CD19, 1, HIB19, Fluidigm, 3142001B, 0171815 147Sm CD20, 1, 2H7, Fluidigm, 3147001B, 2491705 166Er CD24, 1, ML5, Fluidigm, 3166007B, 2651709 149Sm CD25 (IL-2R), 1, 2A3, Fluidigm, 3149010B, 1931712 6 nature portfolio | rep orting sum m ary April2023 167Er CD27, 1, L128, Fluidigm, 3167006B, 3501404 172Yb CD38, 1, HIT2, Fluidigm, 3172007B, 1931716 171Yb CD44, 0.1, IM7, Fluidigm, 3171003B, 1931725 & 3421608 89Y CD45, 1, HI30, Fluidigm, 3089003B, 3421702 165Ho CD45RO, 1, UCHL1, Fluidigm, Conjugation Assay:Article Title: Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study Article Snippet: .. The list of CyTOF Abs used in this work: Metal Isotope, Antibody, Ab Amount (μl), Clone, Manufacturer, Catalogue#, LOT# (whenever available; if more than one LOT was used, they are split by '&') 154Sm CD3, 1, UCHT1, Fluidigm, 3154003B, 0151806 174Yb CD4, 1, SK3, Fluidigm, 3174004B, 2351715 146Nd CD8a, 1, RPA-T8, Fluidigm, 3146001B,1671716 209Bi CD11b, 1, ICRF44, Fluidigm, 3209003B, 0831723 160Gd CD14, 1, M5E2, Fluidigm, 3160001B, 3261702 164Dy CD15 (SSEA-1), 1, W6D3, Fluidigm, 3164001B, 1421725 148Nd CD16, 1, 3G8, Fluidigm, 3148004B, 2511709 142Nd CD19, 1, HIB19, Fluidigm, 3142001B, 0171815 147Sm CD20, 1, 2H7, Fluidigm, 3147001B, 2491705 166Er CD24, 1, ML5, Fluidigm, 3166007B, 2651709 149Sm CD25 (IL-2R), 1, 2A3, Fluidigm, 3149010B, 1931712 6 nature portfolio | rep orting sum m ary April2023 167Er CD27, 1, L128, Fluidigm, 3167006B, 3501404 172Yb CD38, 1, HIT2, Fluidigm, 3172007B, 1931716 171Yb CD44, 0.1, IM7, Fluidigm, 3171003B, 1931725 & 3421608 89Y CD45, 1, HI30, Fluidigm, 3089003B, 3421702 165Ho CD45RO, 1, UCHL1, Fluidigm, Antibody Labeling:Article Title: Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study Article Snippet: .. The list of CyTOF Abs used in this work: Metal Isotope, Antibody, Ab Amount (μl), Clone, Manufacturer, Catalogue#, LOT# (whenever available; if more than one LOT was used, they are split by '&') 154Sm CD3, 1, UCHT1, Fluidigm, 3154003B, 0151806 174Yb CD4, 1, SK3, Fluidigm, 3174004B, 2351715 146Nd CD8a, 1, RPA-T8, Fluidigm, 3146001B,1671716 209Bi CD11b, 1, ICRF44, Fluidigm, 3209003B, 0831723 160Gd CD14, 1, M5E2, Fluidigm, 3160001B, 3261702 164Dy CD15 (SSEA-1), 1, W6D3, Fluidigm, 3164001B, 1421725 148Nd CD16, 1, 3G8, Fluidigm, 3148004B, 2511709 142Nd CD19, 1, HIB19, Fluidigm, 3142001B, 0171815 147Sm CD20, 1, 2H7, Fluidigm, 3147001B, 2491705 166Er CD24, 1, ML5, Fluidigm, 3166007B, 2651709 149Sm CD25 (IL-2R), 1, 2A3, Fluidigm, 3149010B, 1931712 6 nature portfolio | rep orting sum m ary April2023 167Er CD27, 1, L128, Fluidigm, 3167006B, 3501404 172Yb CD38, 1, HIT2, Fluidigm, 3172007B, 1931716 171Yb CD44, 0.1, IM7, Fluidigm, 3171003B, 1931725 & 3421608 89Y CD45, 1, HI30, Fluidigm, 3089003B, 3421702 165Ho CD45RO, 1, UCHL1, Fluidigm, other:Article Title: Unsupervised Clustering of Cell Populations in Germinal Centers Using Multiplexed Immunofluorescence Article Snippet: CD45RO , 165Ho , Article Title: Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial Article Snippet: Anti-Human CD45RO (UCHL1) 165Ho , Article Title: Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma Article Snippet: CD45RO (UCHL1) , |